Skip to content
OpenCapital
Get started

Cumberland Pharmaceuticals CPIX RediTrex — Revenues, including adjustments

Similar metrics at other companies

Organon logo
OGNRenflexis — Revenue
$57M0.0%
Esperion Therapeutics logo
ESPRProduct sales, net — Total Revenues
$43.4M+24.3%
Supernus Pharmaceuticals logo
SUPNTrokendi XR — Total revenues
$9.48M-26.0%
Amgen logo
AMGNKRYSTEXXA — Total revenues
$255M+8.1%
Rhythm Pharmaceuticals, Inc. logo
RYTMProduct revenue, net — Total revenues
$60.11M+59.4%
Pacira BioSciences, Inc. logo
PCRXZILRETTA — Total net product sales
$26.77M+14.7%

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+138%
Enterprise value$90.91M+207%
P/S2.3×+1.3×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%—

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio1×-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept cpix:RevenueFromContractWithCustomerExcludingAssessedTaxIncludingAdjustments.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's reditrex — revenues, including adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's reditrex — revenues, including adjustments?
Cumberland Pharmaceuticals (CPIX) reported reditrex — revenues, including adjustments of -$489 in Q1 2026.
How has Cumberland Pharmaceuticals's reditrex — revenues, including adjustments changed year-over-year?
Cumberland Pharmaceuticals's reditrex — revenues, including adjustments decreased by 40.9% year-over-year, from -$347 to -$489.
What does reditrex — revenues, including adjustments mean?
This metric represents the total net sales generated by the RediTrex product line after accounting for all relevant adjustments, such as returns, rebates, and other sales deductions. It provides a comprehensive view of the actual economic value realized from the product's commercialization activities. Investors use this figure to assess the net market demand and the effectiveness of the company's pricing and distribution strategies for this specific pharmaceutical asset.